The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX200 has been up around 0.6% of a percent at 8,198 points in early afternoon trade.

The labour day holiday in some states has seen the bourse trading in lower volumes, as investors continue to digest the unfolding conflict in the Middle East.

The sectors are a mixed bag, and both Financials and IT have been leading the market higher – both up 1.35%, followed by Materials up 0.65%.

Company News

Mining giant Rio Tinto (ASX:RIO) has been down 1.5% on news it has made a takeover approach to Arcadium Lithium (ASX:LTM). Rio has confirmed the potential acquisition, but has underscored there is no guarantee the takeover will go ahead. The company says it will update the market when appropriate.

Rio has been trading at $122.05 and Arcadium Lithium has been up 43% at $6.00.

Evolution Mining (ASX:EVN) has been down around 2% after broker Jefferies downgraded the gold miner to a hold rating. However, the broker lifted its price target by 6.4% to $5.00 amid broad weakness in the gold sector.

Evolution Mining has been $4.53.

Neuren Pharmaceuticals (ASX:NEU) has been up 2.3% after taking a step closer to FDA approval for its Phase 3 trial to treat children with Phelan-McDermid Syndrome (PMS).

Neuren Pharmaceuticals has been $14.37.

More From The Market Online
The Market Online Video

ASX Market Close: Iron Ore falls after China stimulus disappoints investors | October 8, 2024

The ASX200 closed down 0.35% at 8,176 points. Iron ore prices fell from US$114/tn to US$108/tn…
A yurt located on some Mongolian plane

TMK Energy kicks off drilling for new pilot wells in Mongolia’s vastly underexplored Gobi

TMK Energy (ASX:TMK) has kicked off a fresh round of drilling at its mammoth Gurvantes XXXV…
The Market Online Video

ASX Market Update: Rinehart down sizes Mulga Downs iron ore mine | October 8, 2024

The ASX200 has been down 0.11% at 8,205 points in early afternoon trade. Investors’ bullish expectations…
Burn wound care

Orthocell wins first international approval for nerve repair product

West Australia-based regenerative medicine play Orthocell (ASX: OCC) has received regulatory approval from the Health Sciences…